2016 A Profile of Bio-pharma Consolidation Activity 45
The following section analyzes FTC assessments and consent orders resulting from premerger notification review in order to further characterize their substance and scope.
III. FTC ENFORCEMENTS ACTIVITY: A MODEST SAMPLE
This section draws from three reports published by the FTC. The first is a March 2013 report by the FTC Health Care Division that provides an overview of select antitrust actions in pharmaceutical services and products spanning 1989 through early 2013.81 The second and third are joint FTC Bureau of Competition and DOJ Antitrust Division Hart-Scott-Rodino annual reports for fiscal year 2013 and 2014 that identify merger enforcement activity resulting from premerger notifications. 82 In total, these three reports detail fifty-four relevant bio-pharma mergers and acquisitions scrutinized by the FTC from FY 1989-2014. Table 1 provides a listing of these fifty-four enforcement actions initiated by the FTC as described in these three reports. The format of the references correspond directly to the reference provided in each report. ———————————————––––––––––––––––––––––––––––––– TABLE 1: FTC REPORTS ENFORCEMENT ACTION TALLIES (ALPHABETICAL ORDER) ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– FTC Bureau of Competition, Health Care Division, Overview of FTC Antitrust Actions in Pharmaceutical Services and Products, March 2013 (45 Total) ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– Actavis/Abrika83 Allergan/Inamed84 American Home Products/American Cyanamid85 Amgen/Immunex86
81. FTC ANTITRUST ACTIONS, supra note 62. 82. RAMIREZ & BAER supra note 77; EDITH RAMIREZ & WILLIAM J. BAER, FED. TRADE COMM’N & DEP’T OF JUSTICE, HART-SCOTT-RODINO ANNUAL REPORT: FISCAL YEAR 2014 (2014), available at https://www.ftc.gov/system/files/documents/reports/federal-trade- commission-bureau-competition-department-justice-antitrust-division-hart-scott- rodino.s.c.18a-hart-scott-rodino-antitrust-improvements-act-1976/150813hsr_report.pdf. 83. Actavis Grp. hf., F. T.C. No. 0710063 (May 18, 2007), https://www.ftc.gov/ sites/default/files/documents/cases/2007/05/070522do0710063.pdf. 84. Allergan, Inc., F. T.C. No. 0610031 (Apr. 17, 2006), https://www.ftc.gov/sites/ default/files/documents/cases/2006/04/0610031allerganinameddecisionandorderpublicrecord version.pdf. 85. Am. Home Prods. Corp., 119 F. T.C. 217 (1995). 86. Amgen Inc., et al. 134 F. T.C. 333 (2002).